Thinking beyond intravenous immunoglobulin for Kawasaki disease
- PMID: 37567754
- DOI: 10.1136/archdischild-2023-325843
Thinking beyond intravenous immunoglobulin for Kawasaki disease
Keywords: Allergy and Immunology; Emergency Service, Hospital; Health Care Economics and Organizations; Paediatrics; Rheumatology.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.Arch Dis Child. 2023 Oct;108(10):833-838. doi: 10.1136/archdischild-2023-325639. Epub 2023 May 31. Arch Dis Child. 2023. PMID: 37258054 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical